Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer
Canadian Journal of Gastroenterology and Hepatology · 08.04.2023 · 2023 · 1-6
DOI: 10.1155/2023/6351330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, erschienen am 08.04.2023. Verfasst von Tao Du und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Stomach Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Key Discipline Construction Project.
Abstract (Originalsprache)
Purpose
Our objective was to compare the value of positron emission tomography/magnetic resonance imaging (PET/MRI) with the new imaging agent [68Ga]Ga-DOTA-FAPI-04 and the traditional imaging agent [18F]FDG for the preoperative diagnosis of gastric cancer.
Methods
Forty patients with gastric cancer diagnosed by gastroscopy in gastrointestinal surgery at our hospital from June 2020 to January 2021 were analyzed. All patients underwent simultaneous [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI. The standard uptake value (SUV), fat removal standard uptake value (SUL), and diagnostic sensitivity, specificity, and accuracy for primary and metastatic lesions were compared, and their diagnostic value for different lymph node dissection stages was analyzed.
Results
The median age of the patients in this cohort was 68 years. Twenty-nine patients underwent surgery, and 11 patients underwent gastroscopic biopsy. The SUVmax of primary lesions in the FDG group and the FAPI group was 5.74 ± 5.09 and 8.06 ± 4.88, respectively ( P < 0.01 ); SULmax values were 3.52 ± 2.80 and 5.64 ± 3.25, respectively ( P < 0.01 ). The SUVmax of metastases in the two groups was 3.81 ± 3.08 and 5.17 ± 2.80, respectively ( P < 0.05 ). The diagnostic sensitivities for primary lesions in the FDG group and the FAPI group were 0.72 and 0.94, respectively ( P < 0.05 ). Combined with postoperative pathological staging, there was no difference in diagnostic sensitivity and specificity of lymph node staging between the FDG and FAPI groups ( P > 0.05 ).
Conclusion
Compared with the traditional imaging agent, [68Ga]Ga-DOTA-FAPI-04 has better diagnostic efficiency but no substantial advantage for preoperative lymph node staging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
- Department of Nuclear Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
- Department of Digestive Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China.
ORCID-Profile: Tao Du, Shun Zhang, Xi-Mao Cui, Ren-Hao Hu, Hai-Yan Wang, Jian-Juan Jiang, Jun Zhao, Lan Zhong, Xiao-Hua Jiang
Förderung
- National Natural Science Foundation of China
- Shanghai Key Discipline Construction Project
Zitieren
APA
Du, T., Zhang, S., Cui, X. M., Hu, R. H., Wang, H. Y., Jiang, J. J., Zhao, J., Zhong, L., & Jiang, X. H. (2023). Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology, 2023, 1-6. https://doi.org/10.1155/2023/6351330
Vancouver
Du T, Zhang S, Cui XM, Hu RH, Wang HY, Jiang JJ, et al. Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology. 2023;2023:1-6. doi:10.1155/2023/6351330
BibTeX
@article{Du2023,
author = {Du, Tao and Zhang, Shun and Cui, Xi-Mao and Hu, Ren-Hao and Wang, Hai-Yan and Jiang, Jian-Juan and Zhao, Jun and Zhong, Lan and Jiang, Xiao-Hua},
title = {Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F]FDG PET/MRI in the Preoperative Diagnosis of Gastric Cancer},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2023},
volume = {2023},
pages = {1--6},
doi = {10.1155/2023/6351330}
}
EUVIMED